Jim Cramer, the host of CNBC's "Mad Money," has criticized Super Micro Computer Inc for its recent business update and ...

I have a list of 26 stocks that have joined the Dow Industrials since 1997. I looked at how those stocks performed after ...

Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.

Hims & Hers Health reported third-quarter results that topped Street expectations Monday and said it plans to release a ...

Hims & Hers (HIMS) stock price remained on edge even after the fast-growing telehealth company published strong financial ...

US markets opened higher on Tuesday, as voters across the country headed to the polls in one of the closest-fought presidential races for decades, which carries significant economic consequences.

Seaport Research raised the firm’s price target on Hims & Hers to $32 from $28 and keeps a Buy rating on the shares. The company ...

CVS Caremark and Express Scripts, along with GoodRx and others, are accused of working together to suppress reimbursements to independent pharmacies in at least three class-action lawsuits. Also, Hims ...

Philip Morris (PM) stock is one of the worst to own in November, per data from Schaeffer's Senior Quantitative Analyst Rocky ...

TD Cowen analyst Jonna Kim maintained a Buy rating on Hims & Hers Health (HIMS – Research Report) today and set a price target of ...

Hims & Hers' both revenue channels witness strong revenue growth on the back of solid product demand in the third quarter.

Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...